For as much success as BMW has seen as a German auto manufacturer or otherwise, not every vehicle has been a massive hit with its audience.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the long-term, open-label KINECT® 4 study demonstrating remission of tardive dyskinesia among the majority of patients treated ...

The MG S5 will replace the smaller ZS in the Chinese brand's lineup when it launches in Europe this spring. It rides on the same platform as the MG4 compact hatchback.

Compass Pathways (CMPS) announced the publication of results from the COMP004 study, an observational 52-week follow-up from the Phase 2 ...

An all-new MG4 EV has been uncovered in China, just two years after the current model was launched. The new MG4 is larger ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Airdrie residents expecting fluoridated drinking water this spring will have to wait longer, as the City of Calgary has ...

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

Investors wanted more from Incyte Corp.’s top-line results in hidradenitis suppurativa (HS) from its pivotal phase III Stop-HS trial program with oral small-molecule JAK1 inhibitor povorcitinib in ...